Latest News
Latest News
COVID-19 and psoriasis: Is there a link?
“Infection with COVID-19 has been associated with flares of guttate and pustular psoriasis, and even psoriasis that affects 100% of the skin.”
Latest News
FDA puts partial hold on investigational alopecia areata drug deuruxolitinib
The announcement came after a pulmonary embolism occurred with the 12-mg twice-daily dose in one of the long-term open-label extension studies.
News from the FDA/CDC
FDA fast tracks potential CAR T-cell therapy for lupus
The cellular therapy depletes CD19-positive B cells with the goal of ‘‘resetting’’ the immune system to achieve durable remission.
Conference Coverage
Long-COVID rate may be higher with rheumatic diseases
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients...
Feature
Researchers seek to understand post-COVID autoimmune disease risk
Three large studies link past SARS-CoV-2 infection to new-onset autoimmune disease, but it is not yet clear what drives this relationship.
Conference Coverage
NSAID use may mask MRI findings in a quarter of spondyloarthritis cases
Among nearly one in four patients whose MRI results were initially positive for sacroiliitis, results were negative 6 weeks after NSAIDs were...
From the Journals
Long-COVID patients respond differently to COVID vaccines
Differences could explain why some people experience symptoms for months while others recover faster.
Latest News
New ABIM fees to stay listed as ‘board certified’ irk physicians
Responses to the policy on Twitter included accusations of extortion and denunciations of the ABIM’s “money grab policies.”
Latest News
BMI is a flawed measure of obesity. What are alternatives?
“BMI is trash. Full stop.”
Conference Coverage
Meta-analysis examines cancer risk concern for JAK inhibitors
Although no increased cancer risk was seen vs. methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than...
Conference Coverage
Registry data ‘reassure’ on biologics’ heart attack risk in rheumatoid arthritis
There is no difference in the risk of myocardial infarction with interleukin-6 (IL-6) vs. anti–tumor necrosis factor (TNF) therapy for rheumatoid...